Wednesday's economic reports will be mined for clues on whether the U.S. economy is strong enough for the Fed to become less "patient" this month.
The Reserve Bank of India surprised markets on Wednesday by cutting rates for the second time this year.
Fears Greece may exit the euro and revive the drachma abound, but attempting a return to the currency Athens left behind may be tragic, Goldman said.
"There's going to be significantly more pain this year than there was last year" in the state, a researcher tells CNBC.
More of China's wealthy are participating in the country's biggest annual political event, underscoring the close ties between politics and business.
Target's CEO said the company will cut several thousand jobs within the next two years as part of a $2 billion cost-savings plan.
The hashtag #beefban is blowing up on Twitter after Maharashtra imposed a jail sentence and fine for the sale or possession of the red meat.
It has coffee shops on nearly every corner, bike paths meandering through its charming streets and plentiful green spaces.
Sony announced that Project Morpheus – a virtual reality headset exclusively for the PlayStation 4 – will be available to consumers in the first half of 2016.
The pay gap between bosses and their workers has increased in every region worldwide since the 2008 financial crisis, according to the latest data.
New filings in the divorce of Ken Griffin show the hedge-fund manager makes $68.5 million per month—after taxes.
Barack Obama and his European counterparts agreed to act quickly to impose more sanctions on Russia if Ukraine peace agreements not implemented.
Apple is discussing a settlement in a lawsuit brought by electric car battery maker A123 Systems, which accused them of poaching top engineers.
Jim Cramer sees six issues that could spell disaster ahead for the economy if not addressed now.
The head of the Health and Human Services Department will be at the Supreme Court for make-or-break arguments over a serious challenge to Obamacare.
“Mad Money” host Jim Cramer spots one company getting the best of this bad story.
The U.S. Food and Drug Administration has asked makers of testosterone drugs to change their labeling and marketing.
A group of once high-flying tech names could be set to break out once more, 15 years after they played a starring role in the tech bubble.
A new study titled "Am I Normal?" published Tuesday in the British Journal of Urology reveals the answer to a common question. NBC reports.
The U.S. government can't borrow normally after March 15, setting up a potentially contentious vote to raise the debt limit.